Communiqués Abbott Laboratories Swiss Exchange

Actions

ABT

US0028241000

Equipement, fournitures et distribution médicale

Marché Fermé - Swiss Exchange 17:35:38 27/08/2026			Varia. 5j.	Varia. 1 janv.
90,50 ^CHF	-2,69 %		-2,69 %	-8,59 %

27/08	Abbott Laboratories : un dirigeant cède des actions pour un montant de 46 204 798 $, selon un récent document de la SEC	MT
27/08	Le dispositif de traitement des AVC d'Abbott Laboratories reçoit le marquage CE	MT

Communiqués

27/08	Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke	PR
25/08	Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes	PR
20/08	Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants	PR
17/08	Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare	PR
12/08	Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis	PR
11/08	Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI	PR
28/07	Abbott Laboratories : initiates clinical study to show outcomes for real-world use of TriClip™ in repairing leaky tricuspid heart valve	PU
17/07	Army integrating new handheld device to quickly assess brain injuries	AQ
16/07	Abbott Laboratories : ABT 2026 Q2 Exhibit 99.1 FINAL	PU
16/07	Abbott: Q2 Earnings Snapshot	AQ
16/07	Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance	PR
25/06	Court Considers Whether Growth Claims Were Tall Tales	AQ
25/06	Abbott hosts conference call for second-quarter earnings	PR
24/06	ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing	PR
23/06	New Similac(R) survey finds social media pressure to be 'perfect' is fueling a shift toward authenticity for the next generation of parents	AQ
22/06	New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents	PR
18/06	Big Claims, Little Kids: Recent SDNY Decision Highlights Risks In Advertising	AQ
12/06	Abbott declares 410th consecutive quarterly dividend	PR
08/06	New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers	PR
06/06	New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis	PR
27/05	Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes	PR
27/05	ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening	PR
26/05	Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026	PR
30/04	Abbott Laboratories : to highlight expanding cancer diagnostic portfolio and clinical evidence at Digestive Disease Week (DDW) 2026	PU
28/04	Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform	PR